The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to describe by a prospective observational study the
serious adverse events occurring in patients treated off-label by rituximab for various
auto-immune diseases.